NewEdge Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.97K | Sell |
102
-8,771
| -99% | -$771K | ﹤0.01% | 3246 |
|
|
2025
Q1 | $809K | Buy |
8,873
+607
| +7% | +$55.3K | ﹤0.01% | 1305 |
|
|
2024
Q4 | $713K | Buy |
8,266
+621
| +8% | +$53.6K | ﹤0.01% | 1343 |
|
|
2024
Q3 | $726K | Buy |
7,645
+3,092
| +68% | +$294K | ﹤0.01% | 1256 |
|
|
2024
Q2 | $417K | Buy |
4,553
+377
| +9% | +$34.5K | ﹤0.01% | 1524 |
|
|
2024
Q1 | $379K | Buy |
+4,176
| New | +$379K | ﹤0.01% | 1512 |
|
|
2023
Q1 | – | Sell |
-281
| Closed | -$21.9K | – | 3963 |
|
|
2022
Q4 | $21.9K | Buy |
+281
| New | +$21.9K | ﹤0.01% | 2093 |
|